Facial Injectable Market Share, Size, Trends, Industry Analysis Report, By Product (Collagen & PMMA Microspheres, Botulinum Toxin Type A, Hyaluronic Acid (HA), Calcium Hydroxylapatite (CaHA), Poly-L-lactic Acid (PLLA), and Others); By Application; By End-use; By Region; Segment Forecast, 2024 - 2032
- Published Date:Apr-2024
- Pages: 117
- Format: PDF
- Report ID: PM1307
- Base Year: 2023
- Historical Data: 2019-2022
Report Outlook
Facial Injectable Market size was valued at USD 11.60 billion in 2023. The market is anticipated to grow from USD 13.01 billion in 2024 to USD 33.56 billion by 2032, exhibiting the CAGR of 12.6% during the forecast period.
Market Overview
Rising focus on aesthetic appearance, innovations in dermal fillers, and ongoing research and development for cost-effective and longer-lasting facial injectables are key factors inducing market growth. Facial injectables are gel-like substances injected beneath the skin to restore a more youthful appearance. These fillers are commonly used in cosmetic procedures to smooth out wrinkles, add volume to lips and restore lost facial volume.
Further, hyaluronic acid fillers are a popular and safe choice due to their effectiveness. When injected into the skin, hyaluronic acid fillers can add volume and plump up the skin, making wrinkles and folds less noticeable. Additionally, HA injections are used to reduce wrinkles in the face and for soft tissue augmentation. Approximately 50% of total HA is found in the skin, which is produced by certain cells in the human body.
To Understand More About this Research:Request a Free Sample Report
- For instance, according to the report published by the American Society of Plastic Surgeons Procedural Statistics Release, in 2022, lip augmentation with fillers accounted for 8% growth over the previous year.
Growth Factors
High rate of FDA approvals is a significant catalyst for facial injectables market growth.
New facial injectables are constantly being developed, approved, and marketed, powering market growth. The major key players operating in the facial injectable market have a portfolio of dermal fillers with various approved indications in the U.S. as well as other major markets around the world to treat various face aesthetics, such as augmenting or treating volume loss in the chin, cheeks, lower face, and lips. As a result, a strong focus on the launch of novel products in the international market is accelerating the facial injectables market growth.
- For instance, in March 2024, Allergan Aesthetics announced that the U.S. Food and Drug Administration (FDA) approved Juvéderm Voluma XC for use in the upper face.
The increasing adoption of facial injectables among the male population is proliferating the market growth.
Growing awareness among men regarding the benefits of facial injectables has augmented the market growth. Additionally, social media and technology have also had a significant influence on the demand for facial injectables by driving awareness and acceptance among male end-users. The rising prevalence of minimally invasive cosmetic surgeries among the male population is fostering the facial injectables market growth across the globe.
- For instance, according to data compiled by the Aesthetic Society and the American Society of Plastic Surgeons, male plastic surgery accounted for approximately 13% of all procedures performed between 2020 and 2023.
Restraining Factors
Adverse side effects of facial injectables is likely to limit the market growth.
Facial injectables may not be appropriate for people with certain conditions, such as allergies or bleeding disorders. Some fillers may be contaminated with chemicals and infectious organisms that are not approved by the FDA (U.S. Food and Drug Administration). Some of the common side effects of facial injectables include swelling, itching, rash, and bruising.
Report Segmentation
The market is primarily segmented based on product, application, end-use, and region.
|
By Product |
By Application |
By End-use |
By Region |
|
|
|
|
To Understand the Scope of this Report:Speak to Analyst
By Product Insights
Hyaluronic Acid (HA) segment held the largest market share
The Hyaluronic Acid (HA) segment holds the largest market share in 2023 and is also anticipated to grow at the fastest CAGR over the forecast period. This dominance is due to its high adoption rate. HA-based facial injectables are considered as gold standard in facial aesthetics due to their documented safety profiles, higher efficacy, and reversibility. In 2020 alone, nearly 2.6 Mn procedures were performed in the U.S. alone. Moreover, this procedure is also highly recommended by healthcare practitioners. There are also several FDA-approved brands of HA-based fillers, with popular names including Juvederm Ultra, Restylane, and Belotero Balances. For instance, according to the article published by the International Society of Aesthetic Plastic Surgery, in 2023, there was a notable increase of approximately 30.3% in hyaluronic acid injections.
By Application Insights
Facial Line Correction segment accounted for the largest market share in 2023
The facial line correction segment garnered the largest share. This is due to the aging population seeking non-surgical solutions to address these signs of aging, which has fueled the demand for facial injectables. Further, the demand for non-invasive surgical procedures has surged with an increase in awareness about early skin aging and facial aesthetic treatments. For instance, in 2023, Galderma announced the FDA approval of Sculptra for the correction of fine lines and wrinkles in the cheek area.
The lip augmentation segment is anticipated to grow at the fastest CAGR over the forecast period. Lip augmentation is a common cosmetic procedure done primarily to improve the aesthetics of the lips. Social media influencers are driving consumer interest towards lip enhancement treatments. Additionally, the consumer shift towards minimally invasive procedures is another influencing factor that will boost the demand for facial injectables in the following years. For instance, according to the report published by the Aesthetic Society, the number of lip enhancement procedures amounted to 8,030 in 2021 and 9,768 in 2022, an increase of 22% from the previous year.
By End-use Insights
MedSpa segment held the significant market revenue share in 2022
The MedSpa segment accounted for the largest market share in 2022 and is projected to grow at the fastest CAGR throughout the forecast period. The rising popularity of minimally invasive cosmetic procedures will foster the demand for medical spas for non-surgical cosmetic treatments. Also, the increasing number of medical spas is a prominent factor that is expected to surge the demand for facial injectables soon. For instance, according to statistics published by the American Med Spa Association, the number of medical spas in the U.S. amounted to 8,841 in 2022, up from 7,430 in 2021.
Regional Insights
The North American region dominated the global market in 2022.
North America dominated the global market. This dominance is attributed to the high rate of FDA approvals, new product launches, and stronger adoption among consumers. Moreover, the region has a higher proportion of women with high discretionary income, which plays a pivotal role in the adoption of facial injectables, coupled with publicity from media and celebrities. For instance, according to the statistics reported by the International Society of Aesthetic Plastic Surgery (ISAPS), the U.S. accounted for the number one position worldwide.
Asia Pacific is expected to grow rapidly. This growth is due to rising disposable income, social media influencers, and medical tourism for aesthetic procedures in low-cost nations. Moreover, the growing popularity of K-pop and K-drama has contributed to the acceptance of a culture of plastic surgery to enhance facial aesthetics. For instance, according to the International Society of Aesthetic Plastic Surgeons, South Korea has the globe’s highest number of cosmetic procedures per capita.
Key Market Players & Competitive Insights
Strategic partnerships to drive the competition
The facial injectable market is fragmented with presence of small and big players. Key players operating in the market are strongly focused on the development of new products. These players focus on new partnerships and collaborations to maintain a competitive advantage to secure a significant market share.
Some of the major players operating in the global market include:
- Allergan Aesthetics (AbbVie Inc.) (U.S.)
- BIOPLUS CO., LTD. (Korea)
- Bioxis Pharmaceuticals (France)
- GALDERMA (Switzerland)
- Ipsen Pharma (France)
- Merz Pharma (Germany)
- Medytox (South Korea)
- Prollenium Medical Technologies (Canada)
- Revance Therapeutics, Inc. (U.S.)
- Sinclair (Huadong Medicine Co., Ltd.) (UK)
- Teoxane (Switzerland)
- Zimmer Aesthetics (Germany)
Recent Developments in the Industry
- ·In May 2023, AbbVie announced that the FDA approved Skinvive by the Juvederm to improve the skin smoothness of the cheeks in adults aged 21 or more.
- ·In January 2024, Medytox announced to establishment new U.S. subsidiary named Luvantas in California.
Report Coverage
The facial injectable market report emphasizes on key regions across the globe to provide better understanding of the product to the users. Also, the report provides market insights into recent developments, trends and analyzes the technologies that are gaining traction around the globe. Furthermore, the report covers in-depth qualitative analysis pertaining to various paradigm shifts associated with the transformation of these solutions.
The report provides detailed analysis of the market while focusing on various key aspects such as competitive analysis, product, application, end-use, and their futuristic growth opportunities.
Facial Injectable Market Report Scope
|
Report Attributes |
Details |
|
Market size value in 2024 |
USD 13.01 billion |
|
Revenue forecast in 2032 |
USD 33.56 billion |
|
CAGR |
12.6% from 2024 – 2032 |
|
Base year |
2023 |
|
Historical data |
2019 – 2022 |
|
Forecast period |
2024 – 2032 |
|
Quantitative units |
Revenue in USD billion and CAGR from 2023 to 2032 |
|
Segments covered |
|
|
Regional scope |
|
|
Competitive Landscape |
Company Profiles/Industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments |
|
Report Format |
PDF + Excel |
|
Customization |
Report customization as per your requirements with respect to countries, country and segmentation. |
FAQ's
The global facial injectable market size is expected to reach USD 33.56 billion by 2032
Key players in the market are Allergan Aesthetics (Abbvie Inc.), GALDERMA, Merz Pharma
North American contribute notably towards the global Facial Injectable Market
Facial Injectable Market exhibiting the CAGR of 12.6% during the forecast period.
The Facial Injectable Market report covering key segments are product, application, end-use, and region.
